October 11, 2009
Aquinox Pharmaceuticals selects AQX-1125 as lead clinical candidate
October 13, 2009
Aquinox Pharmaceuticals to present at BioPartnering Europe.
Click here for our latest slide presentation.

Aquinox Pharmaceuticals is a pharmaceutical company committed to the discovery, development, and commercialization of novel and targeted small molecule therapeutics for the treatment of cancer and inflammatory disease.
